JP2005528374A5 - - Google Patents

Download PDF

Info

Publication number
JP2005528374A5
JP2005528374A5 JP2003581743A JP2003581743A JP2005528374A5 JP 2005528374 A5 JP2005528374 A5 JP 2005528374A5 JP 2003581743 A JP2003581743 A JP 2003581743A JP 2003581743 A JP2003581743 A JP 2003581743A JP 2005528374 A5 JP2005528374 A5 JP 2005528374A5
Authority
JP
Japan
Prior art keywords
alkyl
carbon atoms
group
amino
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003581743A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005528374A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2003/003434 external-priority patent/WO2003084503A2/en
Publication of JP2005528374A publication Critical patent/JP2005528374A/ja
Publication of JP2005528374A5 publication Critical patent/JP2005528374A5/ja
Pending legal-status Critical Current

Links

JP2003581743A 2002-04-05 2003-04-02 粘液分泌過多の治療方法 Pending JP2005528374A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02007699 2002-04-05
PCT/EP2003/003434 WO2003084503A2 (en) 2002-04-05 2003-04-02 P38 kinase inhibitors for treating mucus hypersecretion_

Publications (2)

Publication Number Publication Date
JP2005528374A JP2005528374A (ja) 2005-09-22
JP2005528374A5 true JP2005528374A5 (enExample) 2006-06-01

Family

ID=28685842

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003581743A Pending JP2005528374A (ja) 2002-04-05 2003-04-02 粘液分泌過多の治療方法

Country Status (14)

Country Link
EP (1) EP1494645A2 (enExample)
JP (1) JP2005528374A (enExample)
KR (1) KR20040101398A (enExample)
CN (1) CN1658834A (enExample)
AU (1) AU2003224025A1 (enExample)
BR (1) BR0309009A (enExample)
CA (1) CA2479520A1 (enExample)
IL (1) IL163737A0 (enExample)
MX (1) MXPA04009605A (enExample)
NZ (1) NZ536278A (enExample)
PL (1) PL372963A1 (enExample)
RU (1) RU2004132847A (enExample)
WO (1) WO2003084503A2 (enExample)
ZA (1) ZA200406910B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070010529A1 (en) * 2003-05-19 2007-01-11 Kanji Takahashi Nitrogenous heterocyclic compounds and medical use thereof
US8309562B2 (en) 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
US8258145B2 (en) 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
WO2006137421A1 (ja) * 2005-06-21 2006-12-28 Kyowa Hakko Kogyo Co., Ltd. 局所投与剤
FR2903774B1 (fr) * 2006-07-17 2008-09-05 Renault Sas Procede de validation d'un diagnostic de fontionnement d'un dispositif.
PE20110598A1 (es) 2008-10-02 2011-08-31 Respivert Ltd Inhibidores de las enzimas de proteina cinasa activadas por mitogeno p38
GB0818033D0 (en) 2008-10-02 2008-11-05 Respivert Ltd Novel compound
MX2011006220A (es) 2008-12-11 2011-06-28 Respivert Ltd Inhibidores de la proteina cinasa activada por el mitogeno p38.
GB0905955D0 (en) 2009-04-06 2009-05-20 Respivert Ltd Novel compounds
PT3691620T (pt) 2017-10-05 2022-10-06 Fulcrum Therapeutics Inc Os inibidores da quinase p38 reduzem a expressão de dux4 e genes a jusante para o tratamento de fshd
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6184226B1 (en) * 1998-08-28 2001-02-06 Scios Inc. Quinazoline derivatives as inhibitors of P-38 α
ID30176A (id) * 1999-03-12 2001-11-08 Boehringer Ingelheim Pharma Senyawa-senyawa yang bermanfaat sebagai zat anti-inflamasi
WO2000071535A1 (en) * 1999-05-21 2000-11-30 Scios Inc. INDOLE-TYPE DERIVATIVES AS INHIBITORS OF p38 KINASE
NZ517578A (en) * 1999-08-19 2004-02-27 Signal Pharm Inc Pyrazoloanthrone and derivatives thereof as JNK inhibitors and their compositions
TR200200673T2 (tr) * 1999-09-17 2002-12-23 Smithkline Beecham Corporation Rinovirüs enfeksiyonlarında csaıd'lerin kullanılması
ATE346064T1 (de) * 2000-09-15 2006-12-15 Vertex Pharma Pyrazolverbindungen als protein-kinasehemmer
WO2002032862A2 (en) * 2000-10-19 2002-04-25 Smithkline Beecham Corporation Use of p38 inhibitors for the treatment of smoke inhalation
EP1381594A1 (en) * 2001-04-13 2004-01-21 Boehringer Ingelheim Pharmaceuticals Inc. Urea compounds useful as anti-inflammatory agents
EP1453515A4 (en) * 2001-11-09 2006-11-29 Scios Inc METHOD FOR TREATING CYSTIC FIBROSIS

Similar Documents

Publication Publication Date Title
RU2004133034A (ru) Новые фармацевтические композиции на основе антихолинергических средств и ингибиторов киназы р38
JP2005529098A5 (enExample)
JP2002539198A5 (enExample)
RU2001122111A (ru) Ароматические гетероциклические соединения в качестве противовоспалительных агентов
JP2003514808A5 (enExample)
JP2005528374A5 (enExample)
CA2352524A1 (en) Aromatic heterocyclic compounds as antiinflammatory agents
YU88491A (sh) Amidi izoksazol-4-karboksilne kiseline i amidi hidroksialkiliden-cijanosirćetne kiseline i postupak za dobijanje farmaceutskih preparata koji sadrže ta jedinjenja
CA2511970A1 (en) Urea derivatives useful in the treatment of heart failure
JP2002539206A5 (enExample)
JP2008525502A5 (enExample)
JP2005503400A5 (enExample)
CN106243088B (zh) 取代的哌嗪化合物及其使用方法和用途
US20040110755A1 (en) Combination therapy with p38 MAP kinase inhibitors and their pharmaceutical compositions
EP1427412A1 (en) Methods of treating cytokine mediated diseases
JP2008509177A5 (enExample)
RU2004132847A (ru) Способ лечения гиперсекреции слизи
JP2020527575A5 (enExample)
JP2005538066A5 (enExample)
WO2009059030A1 (en) Pyrazole derivatives as kinase inhibitors
WO2004016267A1 (en) Anticoagulant and fibrinolytic therapy using p38 map kinase inhibitors
US20030220336A1 (en) Method of treating mucus hypersecretion
DE60310730T2 (de) Pharmazeutische zusammensetzungen aus anticholinergica und p38 kinase hemmern zur behandlung von erkrankungen der atemwege
RU2527561C2 (ru) Ингибиторы протеинфосфатазы-1 и их применение
RU2021102256A (ru) Производные хиназолина биарилэфирного типа